ibl.ai Agentic AI Blog

Insights on building and deploying agentic AI systems. Our blog covers AI agent architectures, LLM infrastructure, MCP servers, enterprise deployment strategies, and real-world implementation guides. Whether you are a developer building AI agents, a CTO evaluating agentic platforms, or a technical leader driving AI adoption, you will find practical guidance here.

Topics We Cover

Featured Research and Reports

We analyze key research from leading institutions and labs including Google DeepMind, Anthropic, OpenAI, Meta AI, McKinsey, and the World Economic Forum. Our content includes detailed analysis of reports on AI agents, foundation models, and enterprise AI strategy.

For Technical Leaders

CTOs, engineering leads, and AI architects turn to our blog for guidance on agent orchestration, model evaluation, infrastructure planning, and building production-ready AI systems. We provide frameworks for responsible AI deployment that balance capability with safety and reliability.

Back to Blog

Why 40% of Healthcare Leaders Pause AI Over Unpredictable Costs, and What Fixes It

ibl.aiNovember 18, 2026
Premium

A Google Cloud survey of 250+ healthcare executives found only 30% have scaled agentic AI and 40% cite unpredictable costs as a reason for pausing. The fix is a cost architecture the health system can meter, cap and move between models.

The Short Answer

Healthcare AI stalls at scale because costs that were invisible in a pilot become unforecastable in production. The fix is architectural: meter every agent, cap spend, and route each workflow to the cheapest model that does the job. On ibl.ai you own all the code and the data, so the health system controls all three.

The numbers come from a Google Cloud survey of more than 250 healthcare executives, conducted by Hypothesis Group and reported by Healthcare Dive on November 16, 2026, as part of its HLTH 2026 coverage.

What did Google Cloud's 2026 survey find about healthcare AI scaling and costs?

Google Cloud's survey found that just 30% of healthcare organizations report successfully scaling advanced or agentic AI across their operations, trailing the all-industry benchmark by 13 percentage points.

Nearly 60% of the executives said they had faced integration and deployment challenges moving enterprise AI from pilot to a live system. And 40% cite unpredictable costs as a reason for pausing AI initiatives.

Two more findings frame the cost problem. More than 80% of respondents cite cost as a key hurdle to reducing dependence on their existing AI vendors. About 40% named protection of sensitive data as an especially important consideration, nine points above the benchmark.

Does the survey say 9 in 10 healthcare organizations are scaling AI?

No. Some social posts about the survey claim 9 in 10 healthcare organizations are scaling AI while 4 in 10 abandon it. Healthcare Dive's report of the Google Cloud survey contains no 9-in-10 figure, and its headline finding runs the other way: only 30% have scaled.

The 40% figure is also narrower than "abandon." The survey says 40% cite unpredictable costs as a reason for pausing AI initiatives, not that 40% have walked away from AI.

That distinction matters for a CFO reading it. A paused initiative is a budgeting problem that can be solved; the rest of this post is about how.

Why do healthcare AI costs look affordable in a pilot and unpredictable at scale?

Healthcare AI costs look affordable in a pilot because the pilot is small and runs one workflow. "You don't see that when you're running a 100-person or 200-person pilot," Aashima Gupta, Google Cloud's global director of healthcare, told Healthcare Dive.

At scale, usage stops being a fixed line item. Every prompt, response, retrieval step and agent interaction consumes tokens, as Accenture's CIO's Guide to AI Tokenomics puts it, and agentic workflows multiply them.

Gupta's other point explains the multiplication: "Healthcare is not one workflow — healthcare is many workflows." Prior authorization, coding, discharge summaries and patient messaging each have their own volume, context length and model needs, so one pilot's unit cost says little about the next ten.

Thin hospital margins make the variance hard to absorb. Gupta went as far as saying "healthcare needs a chief token officer."

What is AI tokenomics, and how much can it save a health system?

AI tokenomics is the discipline of measuring and managing what AI consumes against the value it returns. Accenture's guide defines it as connecting "what AI consumes to the value it returns."

Accenture projects that without optimization, token costs grow about 44% over 24 months, driven by 78% volume growth partly offset by a 19% price decline.

Organizations adopting tokenomics disciplines can avoid that projected increase, about $4.4 million for every $10 million of annual spend.

One correction to how that number has been repeated: it is Accenture's projection of avoidable growth, not a measured saving that companies have already banked.

Accenture also reports that only 20 cents of every dollar spent on tokens can today be expressed as a quantified financial outcome to a board or CFO, rising to 32 cents with chargeback and workload-level measurement.

What cost architecture lets a health system scale AI without unpredictable bills?

A health system scales AI predictably when it can do three things itself: see cost per agent and per workflow, cap spend before it happens, and move a workflow to a cheaper model without rebuilding it.

Cost problem the survey namesWhat the health system needsHow it works on ibl.ai
Costs invisible in the pilot, unforecastable at scaleCost per agent, per workflow, per departmentPer-agent usage and spend in Costs analytics
40% pause over unpredictable costsA spend ceiling set in advanceUsage-based billing against a budget cap the health system sets
Many workflows, one model for allModel choice per workflowPer-agent LLM selection, model-agnostic across any provider
80%+ see cost blocking less vendor dependenceA switch that does not require a migrationThe health system holds the source code and switches models anytime
Sensitive data, nine points above benchmarkAgents that read data in placeSelf-hosted inside the health system's own perimeter

Google is pushing an approach that uses different models for different use cases, per Healthcare Dive, rather than one model for all of healthcare. That only saves money if switching a workflow's model is a setting, not a contract renegotiation.

Why does per-seat AI pricing make healthcare costs harder to forecast?

Per-seat AI pricing makes healthcare costs harder to forecast because it charges for headcount while the real cost driver is workload. A clinician who never opens the tool costs the same seat as the one running hundreds of prior authorizations a week.

Seats also hide the token economics underneath, so the 20-cent visibility gap Accenture describes stays closed to the buyer. We worked the per-seat versus usage arithmetic for a 5,000-clinician system in AI cost math for hospitals.

ibl.ai runs with no per-seat pricing, model-agnostic, and can deploy anywhere from the health system's own cloud to a fully air-gapped network. Usage is metered, so the token bill is visible, capped and attributable to a workflow.

What should a health system do before scaling its next AI pilot?

Before scaling the next pilot, a health system should be able to answer four questions from its own data, because 40% of its peers paused when they could not.

First, what does one completed task cost, per agent, at the pilot's volume? Second, what volume does production imply, workflow by workflow? Third, what is the spend cap, and what happens when it is hit? Fourth, which workflows could run on a smaller model at acceptable quality?

The fourth question is where the 19% price decline Accenture projects over 24 months becomes the health system's saving rather than the vendor's margin, but only if the health system can move the workload.

ibl.ai is family-owned and operated from New York, NY, and its engineers build alongside a health system's own team, so the cost model is designed with the people who will run it.

Sources: survey findings and Aashima Gupta quotes from Healthcare Dive, November 16, 2026, reporting a Google Cloud survey of 250+ healthcare executives by Hypothesis Group; token-cost projections from Accenture, The CIO's Guide to AI Tokenomics. Healthcare Dive's report of the survey gives 30% as having scaled agentic AI and contains no 9-in-10 figure. The 40% figure is a reason for pausing, not abandoning.

Why does owning the AI stack matter?

ibl.ai is the agentic AI platform where you own all the code and the data. You self-host the entire stack inside your own perimeter, run it model-agnostic across any LLM and switch anytime, and pay by usage with no per-seat pricing — so you can deploy anywhere: your cloud, on-premise, GovCloud, or fully air-gapped.

  • You own all the code and the data

    Full source code under a perpetual license, running on your infrastructure. Not API access to someone else's platform — the stack itself is yours.

  • Model-agnostic

    Run any LLM — Claude, GPT, Gemini, Llama, Command, or your own fine-tune — and switch providers without rewriting the platform.

  • No per-seat pricing

    Usage-based billing against a budget cap you set. Cost tracks what your organization actually uses, not how many people you employ.

  • Deploy anywhere

    Your cloud, your VPC, on-premise, GovCloud, or a fully air-gapped network with no outbound connectivity.

1.6M+ users across 400+ organizations run the platform this way, including NVIDIA, MIT, and Syracuse University.

ibl.ai is family-owned and operated from New York, NY — a U.S.-headquartered, domestically-owned long-term partner, not a vendor that sells licenses and moves on.

Related Articles

See the ibl.ai AI Operating System in Action

Discover how leading universities and organizations are transforming education with the ibl.ai AI Operating System. Explore real-world implementations from Harvard, MIT, Stanford, and users from 400+ institutions worldwide.

View Case Studies
Work with our team

Pilots, deployment, and full ownership

Every engagement is scoped to the work: you integrate ibl.ai with your own data, deploy it on your own infrastructure, and the engineering hours scale with the scope — so the price tracks the scope, not your headcount. Most customers keep us on afterwards for platform updates, new agents and integrations, and ongoing services.

Start here

Pilot

from $15K

fixed scope · fixed timeline

A time-boxed proof of value on your real data — not a slide deck.

Best for: Teams that want to see ibl.ai working before committing.

  • Deployed on your infrastructure or our cloud
  • 1–2 production agents wired to a slice of your data
  • One integration (LMS / SIS / SSO / data source)
  • Weekly working sessions with our engineers
  • Pilot fee credits toward a full engagement
Scope a pilot
Most common

Integration & Deployment

$25K – $80K

one-time fee · scoped to the work

Full deployment integrated with your data and systems. Engineering hours scale with scope.

Best for: Organizations rolling ibl.ai out across a department, campus, or business unit.

  • Platform deployed in your VPC, on-prem, or air-gapped
  • Integrated with your data + identity (SSO / SAML)
  • Multiple custom agents built to your workflows
  • Engineering hours proportional to scope
  • You own the data · run any LLM you choose
Plan a deployment
Full ownership

Codebase Transfer + Custom AI Engineering

Custom quote

perpetual license · you own the stack

We transfer the full source code. You own and self-host the entire platform — outright.

Best for: Organizations and enterprises that benefit from perpetual ownership and sovereignty.

  • Complete source-code transfer + perpetual license
  • Dedicated AI engineering team on your roadmap
  • Custom agents, models, and integrations to spec
  • Air-gapped capable · zero vendor lock-in
  • Family-owned, New York–based long-term partner
Talk about ownership
You own the code and data Run any LLM — Claude, GPT, Gemini, Llama Family-owned & operated from New York, NY